The role of interferon epsilon in ovarian cancer

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/2004500

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Ovarian cancer is difficult to diagnose, patients present at a late stage of disease and it responds poorly to therapy. To improve treatment, it is crucial to gain new insights into ovarian cancer biology. We discovered a new protein, interferon epsilon, which is produced naturally by cells lining the female reproductive tract where it protects against infections and may even prevent development of cancers. We plan to characterise the action of IFNe on HGSOC and how best to use it for therapy.

Funded Activity Details

Start Date: 01-01-2020

End Date: End date not available

Funding Scheme: Ideas Grants

Funding Amount: $1,108,015.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer immunology | cancer immunotherapy | mucosal immunology | ovarian cancer

Related Links